ABBV AbbVie, Inc.

86.52-0.68 (-0.78%)
Close: November 21, 2019

86.960.44 (+0.51%)
After hours

Quote

Previous Close
$86.52
Day Range
$85.55-$86.87
52 Week Range
$62.66-$94.98
Volume
9,397,041
Avg Volume
7,883,934
Dividend TTM
$4.28 (4.91%)
Ex-Dividend Date
2020-01-14

Valuation

Market Cap
$127.95B
Enterprise Value (EV)
$161.20B
PE Ratio
39.68
EV/EBITDA
11.59
Price/Sales
3.94
Price/Book
-
PEG Ratio
4.47

Financials

Revenue
$32.75B
Gross Profit
$25.20B
EBITDA
$13.90B
EPS, ttm
$2.18
Profit Margin
17.27%
Revenue/Employee
$1.09M
Next Earnings Date
1/27/2020 (66 days)
Debt to Equity
-477%
Debt
$41.32B
Cash
$8.06B
Net Debt
$33.25B

Performance

Beta
0.88
200 Day Moving Avg
$75.74
50 Day Moving Avg
$77.55
52 Week Change
1.22%
YTD Change
-3.05%
1 Month Change
12.81%
3 Month Change
29.11%
6 Month Change
7.81%
1 Year Change
1.22%
2 Year Change
-6.84%
5 Year Change
33.76%

Share Count

Shares Outstanding
1.5B
Float
1.5B
Restricted Shares
1.6M
Restricted Shares, %
0.11%

AbbVie, Inc. Company Details

Sector: Health Technology

Industry: Pharmaceuticals: Major

CEO: Richard A. Gonzalez

Website: http://www.abbvie.com

Description: AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Employees: 30,000